Literature DB >> 34357554

Immune-microbiome interplay and its implications in neurodegenerative disorders.

Ankit Uniyal1, Vineeta Tiwari1, Mousmi Rani1, Vinod Tiwari2.   

Abstract

The neurodegeneration and its related CNS pathologies need an urgent toolbox to minimize the global mental health burden. The neuroimmune system critically regulates the brain maturation and survival of neurons across the nervous system. The chronic manipulated immunological drive can accelerate the neuronal pathology hence promoting the burden of neurodegenerative disorders. The gut is home for trillions of microorganisms having a mutual relationship with the host system. The gut-brain axis is a unique biochemical pathway through which the gut residing microbes connects with the brain cells and regulates various physiological and pathological cascades. The gut microbiota and CNS communicate using a common language that synchronizes the tuning of immune cells. The intestinal gut microbial community has a profound role in the maturation of the immune system as well as the development of the nervous system. We have critically summarised the clinical and preclinical reports from the past a decade emphasising that the significant changes in gut microbiota can enhance the host susceptibility towards neurodegenerative disorders. In this review, we have discussed how the gut microbiota-mediated immune response inclines the host physiology towards neurodegeneration and indicated the gut microbiota as a potential future candidate for the management of neurodegenerative disorders.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Astrocytes; Gut microbiota; Gut-brain axis; Immune system; Microglia; Neurodegeneration

Mesh:

Year:  2021        PMID: 34357554     DOI: 10.1007/s11011-021-00807-3

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  148 in total

1.  Nonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6.

Authors:  Siddheshvar Bhela; Christine Kempsell; Monali Manohar; Margarita Dominguez-Villar; Russell Griffin; Pooja Bhatt; Pia Kivisakk-Webb; Robert Fuhlbrigge; Thomas Kupper; Howard Weiner; Clare Baecher-Allan
Journal:  J Immunol       Date:  2015-01-30       Impact factor: 5.422

2.  Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.

Authors:  Kerstin Berer; Marsilius Mues; Michail Koutrolos; Zakeya Al Rasbi; Marina Boziki; Caroline Johner; Hartmut Wekerle; Gurumoorthy Krishnamoorthy
Journal:  Nature       Date:  2011-10-26       Impact factor: 49.962

3.  Urate mitigates oxidative stress and motor neuron toxicity of astrocytes derived from ALS-linked SOD1G93A mutant mice.

Authors:  Rachit Bakshi; Yuehang Xu; Kaly A Mueller; Xiqun Chen; Eric Granucci; Sabrina Paganoni; Ghazaleh Sadri-Vakili; Michael A Schwarzschild
Journal:  Mol Cell Neurosci       Date:  2018-06-18       Impact factor: 4.314

Review 4.  Brain-derived neurotrophic factor.

Authors:  Devin K Binder; Helen E Scharfman
Journal:  Growth Factors       Date:  2004-09       Impact factor: 2.511

5.  Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells.

Authors:  Koji Atarashi; Takeshi Tanoue; Minoru Ando; Nobuhiko Kamada; Yuji Nagano; Seiko Narushima; Wataru Suda; Akemi Imaoka; Hiromi Setoyama; Takashi Nagamori; Eiji Ishikawa; Tatsuichiro Shima; Taeko Hara; Shoichi Kado; Toshi Jinnohara; Hiroshi Ohno; Takashi Kondo; Kiminori Toyooka; Eiichiro Watanabe; Shin-Ichiro Yokoyama; Shunji Tokoro; Hiroshi Mori; Yurika Noguchi; Hidetoshi Morita; Ivaylo I Ivanov; Tsuyoshi Sugiyama; Gabriel Nuñez; J Gray Camp; Masahira Hattori; Yoshinori Umesaki; Kenya Honda
Journal:  Cell       Date:  2015-09-24       Impact factor: 41.582

6.  Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice.

Authors:  Kerstin Berer; Lisa Ann Gerdes; Egle Cekanaviciute; Xiaoming Jia; Liang Xiao; Zhongkui Xia; Chuan Liu; Luisa Klotz; Uta Stauffer; Sergio E Baranzini; Tania Kümpfel; Reinhard Hohlfeld; Gurumoorthy Krishnamoorthy; Hartmut Wekerle
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-11       Impact factor: 11.205

7.  Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial.

Authors:  Ghodarz Akkasheh; Zahra Kashani-Poor; Maryam Tajabadi-Ebrahimi; Parvaneh Jafari; Hossein Akbari; Mohsen Taghizadeh; Mohammad Reza Memarzadeh; Zatollah Asemi; Ahmad Esmaillzadeh
Journal:  Nutrition       Date:  2015-09-28       Impact factor: 4.008

8.  Commensal microbiota is fundamental for the development of inflammatory pain.

Authors:  F A Amaral; D Sachs; V V Costa; C T Fagundes; D Cisalpino; T M Cunha; S H Ferreira; F Q Cunha; T A Silva; J R Nicoli; L Q Vieira; D G Souza; M M Teixeira
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

Review 9.  The microglial-motoneuron dialogue in ALS.

Authors:  S H Appel; W Zhao; D R Beers; J S Henkel
Journal:  Acta Myol       Date:  2011-06

Review 10.  Neurodegenerative processes in Huntington's disease.

Authors:  D Bano; F Zanetti; Y Mende; P Nicotera
Journal:  Cell Death Dis       Date:  2011-11-10       Impact factor: 8.469

View more
  1 in total

1.  Nutraceuticals in the Modulation of the Intestinal Microbiota: Current Status and Future Directions.

Authors:  Enzo Spisni; Silvia Turroni; Patrizia Alvisi; Renato Spigarelli; Demetrio Azzinnari; Dario Ayala; Veronica Imbesi; Maria Chiara Valerii
Journal:  Front Pharmacol       Date:  2022-03-18       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.